By Mill Chart
Last update: Jun 25, 2025
NETEASE INC-ADR (NASDAQ:NTES) stands out as a compelling pick for investors seeking growth at a reasonable price (GARP). The company meets key criteria from Peter Lynch’s investment strategy, balancing solid earnings growth, strong profitability, and a conservative financial structure—all while trading at a reasonable valuation.
NETEASE’s financial health is robust, with high marks for profitability and solvency. Key highlights include:
For a deeper dive, review the full fundamental analysis of NTES.
Our Peter Lynch Strategy screener lists more stocks that fit this strategy and is updated daily.
This is not investing advice! The article highlights observations at the time of writing, but you should always conduct your own analysis before making investment decisions.
NASDAQ:NTES (1/9/2026, 11:57:54 AM)
139.04
-2.83 (-1.99%)
Find more stocks in the Stock Screener


